Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis

The Ki-1 antigen (CD30) is an established therapeutic target in patients with Hodgkin lymphoma and anaplastic large-cell lymphoma. We have recently shown that CD30 is expressed abundantly in the cytoplasm of neoplastic mast cells (MCs) in patients with advanced systemic mastocytosis (SM). In the cur...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Blatt, Katharina, Cerny-Reiterer, Sabine, Schwaab, Juliana, Sotlar, Karl, Eisenwort, Gregor, Stefanzl, Gabriele, Hoermann, Gregor, Mayerhofer, Matthias, Schneeweiss, Mathias, Knapp, Sylvia, Rülicke, Thomas, Hadzijusufovic, Emir, Bauer, Karin, Smiljkovic, Dubravka, Willmann, Michael, Reiter, Andreas, Horny, Hans-Peter, Valent, Peter
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2015
Konular:
Myeloid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4692143/
https://ncbi.nlm.nih.gov/pubmed/26486787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-637728
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller